Instalab

Estradiol (E2) Test

Your clearest read on hormone balance through every life stage, from fertility to menopause and beyond.

Should you take a Estradiol (E2) test?

This test is most useful if any of these apply to you.

Going Through or Past Menopause
Your level shows where you are in the transition and helps you plan ahead for bone, heart, and brain health before symptoms get worse.
Trying to Conceive
Read alongside FSH, LH, and AMH, this number clarifies ovarian function and helps your clinician time interventions and treatments.
A Man Watching Your Hormones
In men, both very low and very high levels carry cardiovascular and metabolic risk, especially when read against testosterone.
Managing Hormone-Sensitive Cancer
If you are on aromatase inhibitors or ovarian suppression, serial testing confirms your treatment is suppressing the hormone driving your cancer.

What Moves This Biomarker

Evidence-backed interventions that affect your Estradiol (E2) level

↓ Decrease
Take an aromatase inhibitor (anastrozole, letrozole, exemestane)
These drugs are the standard of care for postmenopausal hormone-receptor-positive breast cancer and work by blocking the enzyme that converts androgens into estradiol. In a study of 706 women on adjuvant aromatase inhibitor therapy, the drugs typically suppressed estradiol substantially, though a meaningful minority of premenopausal women on these drugs with ovarian suppression failed to reach full suppression, which is why serial monitoring is recommended during treatment.
MedicationStrong Evidence
↑ Increase
Use systemic estradiol replacement therapy
Oral, transdermal, or vaginal estradiol replacement raises circulating estradiol in postmenopausal women, restoring it toward premenopausal levels and addressing menopausal symptoms, bone loss, and genitourinary changes. In a randomized trial of 222 healthy postmenopausal women, unopposed oral estradiol slowed progression of subclinical atherosclerosis compared with placebo. Transdermal delivery tends to produce more stable, physiological levels than oral dosing.
MedicationStrong Evidence
↓ Decrease
Take an aromatase inhibitor with weight loss (men with obesity and low testosterone)
In a randomized trial of 23 severely obese men with low testosterone, combining weight loss with an aromatase inhibitor reduced estradiol and raised testosterone, improving the overall hormonal profile without significant side effects. This pattern matters because excess conversion of testosterone to estradiol in fat tissue is a major driver of low testosterone and high estradiol in men with obesity.
MedicationStrong Evidence
↓ Decrease
Lose weight through reduced calories and aerobic exercise
In a randomized trial of 439 overweight or obese postmenopausal women, a reduced-calorie diet combined with moderate-to-vigorous aerobic exercise significantly lowered serum estradiol and free testosterone over 12 months. For postmenopausal women, where most estradiol comes from fat tissue, this is a meaningful intervention because higher endogenous estradiol after menopause is linked to higher breast cancer risk.
LifestyleModerate Evidence
↓ Decrease
Exercise regularly
A meta-analysis of randomized trials in healthy women found that physical activity significantly reduces circulating estrogens and testosterone, with benefits that go beyond what is explained by weight loss alone. This means even leaner women can shift their estradiol downward through regular training, which is relevant for breast cancer risk reduction in postmenopausal life.
ExerciseModerate Evidence
↑ Increase
Drink alcohol regularly
A randomized crossover pilot in 20 postmenopausal breast cancer survivors on aromatase inhibitors found that 5 ounces of white wine daily raised circulating sex hormone levels, potentially undermining the cancer treatment. An earlier randomized trial in postmenopausal women on estrogen replacement found that moderate alcohol intake significantly increased circulating estradiol. A meta-analysis of cohort studies in women confirmed small but consistent rises in sex hormones with alcohol intake. The link is one mechanism behind alcohol's contribution to breast cancer risk.
DietModerate Evidence
↓ Decrease
Smoke cigarettes
In a cohort of 275 postmenopausal women on hormone therapy, current and past smoking was associated with lower serum estradiol levels compared with non-smokers. While lower estradiol might sound protective for breast cancer risk, smoking accelerates bone loss, increases cardiovascular and cancer risk overall, and can blunt the benefit of hormone therapy when prescribed for menopausal symptoms.
LifestyleModerate Evidence
↑ Increase
Carry excess weight as a postmenopausal woman
Higher BMI is consistently associated with higher serum estradiol in postmenopausal women. In a cohort of 275 women on hormone therapy, BMI was a major positive determinant of attained estradiol levels. After menopause, fat tissue becomes the main site of estradiol production through conversion of adrenal androgens, which is one reason obesity raises postmenopausal breast and endometrial cancer risk.
LifestyleModerate Evidence
↓ Decrease
Take metformin
In a randomized placebo-controlled trial of 312 postmenopausal women with hormone-receptor-negative early breast cancer, metformin lowered serum estradiol compared with placebo independently of changes in body weight. The reduction was modest but consistent. The implication is that women taking metformin for diabetes or related conditions may see slightly lower estradiol readings, and the change reflects real biology rather than assay artifact.
MedicationModest Evidence
↑ Increase
Take soy isoflavone supplements
A meta-analysis of randomized trials in men found a dose-related increase in serum estradiol and SHBG with higher soy isoflavone intake, although effects on testosterone were not consistent. In postmenopausal women, a separate meta-analysis found no significant estrogenic effect on standard measures of estrogen activity. The takeaway is that soy supplements may shift estradiol slightly in some populations, but the biological consequences appear small.
SupplementModest Evidence